Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis-Reference-Cited by-同舟云学术

Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis

Published:2018-09 Issue: Volume:14 Page:33-44
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Merchant Sanjay,Proudfoot Emma M.,Quadri Hafsa N.,McElroy Heather J.,Wright William R.,Gupta Ankur,Sarpong Eric M.

Funder

Merck & Co., Inc.

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference51 articles.

1. Appropriate initial antibiotic therapy in hospitalized patients with Gram-negative infections: systematic review and meta-analysis;Raman;BMC Infect Dis,2015

2. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009–2010;Hoban;Diagn Microbiol Infect Dis,2011

3. Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002–2010;Hsueh;Int J Antimicrob Agents,2012

4. The burden of healthcare-associated infections in Southeast Asia: a systematic literature review and meta-analysis;Ling;Clin Infect Dis,2015

5. Gram-negative antibiotic resistance: there is a price to pay;Slama;Crit Care,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morpholinium-based Ionic Liquids as Potent Antibiofilm and Sensitizing Agents for the Control of Pseudomonas aeruginosa;Journal of Molecular Biology;2024-07

2. Management strategies for severe Pseudomonas aeruginosa infections;Current Opinion in Infectious Diseases;2023-10-12

3. Ceftobiprole medocaril for the treatment of pneumonia;Expert Review of Anti-infective Therapy;2023-04-18

4. Cost–effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia;Journal of Comparative Effectiveness Research;2023-03

5. Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal;Antibiotics;2023-02-16